Heart Disease News and Research

Latest Heart Disease News and Research

Lower dose of avosentan drug may provide more favorable results in diabetes patients

The drug avosentan substantially reduces urinary protein loss in people with type 2 diabetes and kidney disease, but the drug causes serious side effects, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

18 Feb 2010

AMICAS postpones Special Meeting of Stockholders to vote on pending merger agreement

AMICAS, Inc., a leader in image and information management solutions, today announced that it will convene and adjourn its Special Meeting of Stockholders to consider and vote on the pending merger agreement with an affiliate of Thoma Bravo, LLC.

18 Feb 2010

CryoLife discloses financial results for fourth-quarter and full-year 2009

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that revenues for the fourth quarter of 2009 increased 12 percent to a quarterly record of $28.6 million compared to $25.5 million for the fourth quarter of 2008. This was the 12th consecutive quarter of profitability for the Company.

18 Feb 2010

Cardiac ablation procedure performed with Stereotaxis System featured on recent BBC documentary

Stereotaxis announced that the recent BBC documentary "From the Heart" included a cardiac ablation procedure performed with the Stereotaxis System by Dr. Muchtiar Khan of OLVG Hospital in Amsterdam. The program's second half, beginning at 10:30 of the 25-minute run time, features extensive scenes from the Stereotaxis procedure.

18 Feb 2010

ScienceWorksForUS reveals how Recovery Act science funding benefits their campuses and communities

On the first anniversary of the American Recovery and Reinvestment Act (ARRA) - the economic stimulus - the nation's research universities today provided nearly 100 examples of how a relatively small element of the measure is paying outsize short- and long-term dividends for the nation. Of the $787 billion contained in the ARRA, $21.5 billion is allocated for research and science infrastructure.

18 Feb 2010

Long-term solution for U.S. medical isotope shortage needed

The medical community has taken additional steps to help alleviate ongoing challenges facing physicians and patients due to the worldwide isotope shortage. SNM cautions that while this is good news, a long-term solution for the U.S. is needed urgently.

18 Feb 2010

La Pitie hospital performs 200 implants of SynCardia temporary CardioWest Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, announced that Groupe hospitalier de la Pitié-Salpétrière (La Pitié) in Paris has performed 200 implants of the Total Artificial Heart, more than any other hospital in the world.

18 Feb 2010

Norwegian government task force suggests formation of single company to commercialise biomaterial assets

Having studied the ethical, judicial and political arguments, the Norwegian government task force has suggested that a single nationwide company should be formed to commercialise biomaterials assets from the country’s various sources. The task force has also recommended HUNT Biosciences be a model for the national company.

18 Feb 2010

Pfizer Canada accepts entries for seventh round of competition for Pfizer CVRAP

Pfizer Canada is currently accepting entries for its seventh round of competition for the Pfizer Cardiovascular Research Awards program (CVRAP). The program, first launched in October 2005, was developed to fund and support independent cardiovascular research in Canada.

18 Feb 2010

AHA Scientific Statement: Only 33% of annual PCIs are performed in women

President Clinton’s stent surgery brought new focus to America’s number-one killer, but it did little to expose the bias that is often present when women seek treatment for a heart attack.

18 Feb 2010

HealthTrust Purchasing Group signs 3-year vascular graft procurement contract with MAQUET Cardiovascular

MAQUET Cardiovascular, LLC, a leading provider of cardiovascular technologies, announced today that it has signed a three year contract with HealthTrust Purchasing Group, LP to provide woven and knitted textile vascular grafts to the HealthTrust membership. The contract includes the HEMASHIELD product line and other vascular grafts, which are used to surgically repair or replace damaged blood vessels, including the aorta.

18 Feb 2010

Phase III data reveals potential of Merck’s GARDASIL in preventing HPV and HPV-related cancers

Merck & Co., Inc. announced today that in new Phase III data, GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] was 77.5 percent (95 percent CI: 39.6, 93.3) efficacious against anal intraepithelial neoplasia (AIN) associated with human papillomavirus (HPV) types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex with men. The data were presented at the European Research Organization on Genital Infection and Neoplasia (EUROGIN) conference in Monte Carlo, Monaco.

18 Feb 2010

Sorin Group's newest generation C5 HLM system receives FDA clearance

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today the U.S. Food and Drug Administration (FDA) clearance of its newest generation C5 Heart-Lung Machine (HLM).

18 Feb 2010

NAMI launches new health education program to promote sound "mind and body" health

The National Alliance on Mental Illness (NAMI) has launched a new health education program to promote sound "mind and body" health practices among individuals who live with serious mental illness.

18 Feb 2010

Pediatric patients face number of cardiac conditions that can impact their health

While heart disease is traditionally associated with adults, pediatric patients face a number of cardiac conditions that can impact their health.

18 Feb 2010

Anti-seizure medication prevents seizures in patients following bleeding stroke: Study

A study by researchers at the University of Cincinnati Neuroscience Institute at University Hospital supports the use of an alternative medication to prevent seizures in patients who have suffered a life-threatening traumatic brain injury or bleeding stroke.

18 Feb 2010

NIA develops CardiacConnections program to drive better patient outcomes

Cardiovascular-related examinations account for more than one in three noninvasive diagnostic imaging procedures in the United States. In response to this growing trend and concerns about clinical appropriateness and affordability, National Imaging Associates, a subsidiary of Magellan Health Services, Inc., developed CardiacConnections™, a cardiac management program designed for the benefit of patients, providers, payers, and the health care industry.

18 Feb 2010

Some heart care costs stay outside insurance coverage, Lowe's does national comparison shopping for employees' heart surgery

MarketWatch reports that though many tout prevention in relation to heart disease, "chances are your insurance won't cover a trip to a dietician, a gym membership or other services that could help you reduce your risk factors."

18 Feb 2010

BG Medicine, Merck collaborate in development of novel biomarker for lipid disorder management

BG Medicine, Inc. today announced that it has entered into a research collaboration with Merck, through a subsidiary, for the development and validation of a novel biomarker with potential application in the management of lipid disorders. BG Medicine will pursue development and validation of an immunoassay and investigate its clinical utility as a biomarker. If successful, BG Medicine plans to complete the development and validation studies and seek regulatory clearance for the test.

18 Feb 2010

Review: Giving employees more flexibility over their work schedules likely to boost their health

A new evidence review suggests that giving employees more flexibility over their work schedules is likely to boost their health as judged by measures like blood pressure and stress. But interventions that are motivated or dictated by the needs of the employer, such as cutting hours, either have no effect on employee health or make it worse.

18 Feb 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Lower dose of avosentan drug may provide more favorable results in diabetes patients

AMICAS postpones Special Meeting of Stockholders to vote on pending merger agreement

CryoLife discloses financial results for fourth-quarter and full-year 2009

Cardiac ablation procedure performed with Stereotaxis System featured on recent BBC documentary

ScienceWorksForUS reveals how Recovery Act science funding benefits their campuses and communities

Long-term solution for U.S. medical isotope shortage needed

La Pitie hospital performs 200 implants of SynCardia temporary CardioWest Total Artificial Heart

Norwegian government task force suggests formation of single company to commercialise biomaterial assets

Pfizer Canada accepts entries for seventh round of competition for Pfizer CVRAP

AHA Scientific Statement: Only 33% of annual PCIs are performed in women

HealthTrust Purchasing Group signs 3-year vascular graft procurement contract with MAQUET Cardiovascular

Phase III data reveals potential of Merck’s GARDASIL in preventing HPV and HPV-related cancers

Sorin Group's newest generation C5 HLM system receives FDA clearance

NAMI launches new health education program to promote sound "mind and body" health

Pediatric patients face number of cardiac conditions that can impact their health

Anti-seizure medication prevents seizures in patients following bleeding stroke: Study

NIA develops CardiacConnections program to drive better patient outcomes

Some heart care costs stay outside insurance coverage, Lowe's does national comparison shopping for employees' heart surgery

BG Medicine, Merck collaborate in development of novel biomarker for lipid disorder management

Review: Giving employees more flexibility over their work schedules likely to boost their health

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in